SHEILA BURNS: Open Payments
NPI 1346853587 · OAK LAWN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$422 in 20 payments from 8 companies in 2025. Trend: 2023 $544 · 2024 $324 · 2025 $422
Food & beverage: $422
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $101 |
| Otsuka America Pharmaceutical, Inc. | 3 | $70 |
| Astellas Pharma US Inc | 3 | $70 |
| Novo Nordisk Inc | 3 | $58 |
| Organon LLC | 2 | $57 |
| ABBVIE INC. | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Amgen Inc. | 1 | $16 |
Products named: REXULTI, Veozah, MOUNJARO, NEXPLANON, Ozempic, JARDIANCE, QULIPTA, FARXIGA.
Industry payments across IL — which companies pay providers there.
